Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             24 results found
no title author magazine year volume issue page(s) type
1 Advances and challenges in neurostimulation for headaches Magis, Delphine
2012
11 8 p. 708-719
12 p.
article
2 Being comatose: why definition matters Wijdicks, Eelco FM
2012
11 8 p. 657-658
2 p.
article
3 Brains: the mind as matter Yaqub, Farhat
2012
11 8 p. 667-
1 p.
article
4 Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study Clark, Christopher M
2012
11 8 p. 669-678
10 p.
article
5 Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment Svenningsson, Per
2012
11 8 p. 697-707
11 p.
article
6 Corrections 2012
11 8 p. 658-
1 p.
article
7 Corrections 2012
11 8 p. 658-
1 p.
article
8 Corrections 2012
11 8 p. 658-
1 p.
article
9 Dag Aarsland: moving Parkinson's disease forward Holmes, David
2012
11 8 p. 665-
1 p.
article
10 Disorders of consciousness: responding to requests for novel diagnostic and therapeutic interventions Jox, Ralf J
2012
11 8 p. 732-738
7 p.
article
11 Functional brain activity and presynaptic dopamine uptake in patients with Parkinson's disease and mild cognitive impairment: a cross-sectional study Ekman, Urban
2012
11 8 p. 679-687
9 p.
article
12 Imaging cerebral amyloid plaques: clinical perspective Herholz, Karl
2012
11 8 p. 652-653
2 p.
article
13 Imaging neural correlates of mild cognitive impairment in Parkinson's disease Monchi, Oury
2012
11 8 p. 653-655
3 p.
article
14 Intracerebral haemorrhage: mechanisms of injury and therapeutic targets Keep, Richard F
2012
11 8 p. 720-731
12 p.
article
15 Is neurology ready to see the light? Holmes, David
2012
11 8 p. 663-664
2 p.
article
16 Is rivaroxaban safer and more effective than warfarin in patients with atrial fibrillation and stroke or TIA? Stöllberger, Claudia
2012
11 8 p. 659-
1 p.
article
17 Is rivaroxaban safer and more effective than warfarin in patients with atrial fibrillation and stroke or TIA? – Author's reply Hankey, Graeme J
2012
11 8 p. 660-661
2 p.
article
18 May, 2012 2012
11 8 p. 666-
1 p.
article
19 Measuring the epilepsy treatment gap in sub-Saharan Africa Winkler, Andrea S
2012
11 8 p. 655-657
3 p.
article
20 News in brief 2012
11 8 p. 668-
1 p.
article
21 Primary or secondary prevention for AD: who cares? Frisoni, Giovanni B
2012
11 8 p. 661-662
2 p.
article
22 Ralf J Jox 2012
11 8 p. 666-
1 p.
article
23 Risk factors associated with the epilepsy treatment gap in Kilifi, Kenya: a cross-sectional study Mbuba, Caroline K
2012
11 8 p. 688-696
9 p.
article
24 The changing landscape of traumatic brain injury research The Lancet Neurology,
2012
11 8 p. 651-
1 p.
article
                             24 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands